|
|
Effect of Bushen Huatan Decoction on bone remodeling balance in ovariectomized osteoporosis rats |
ZHOU Ya′na1* ZHOU Guangwen2* ZHANG Lin3 ZHANG Yan4 TAN Zhangkui4 LI Zhangqing4 HUANG Shiyi4 XIONG Mengxin4 XIANG Nan4 |
1.Department of Oncology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province, Wuhan 430061, China;
2.College of Acupuncture and Bone Injury, Hubei University of Chinese Medicine, Hubei Province, Wuhan 430065, China;
3.Department of Osteoarticular Surgery, Wuhan Hospital of Traditional Chinese and Western Medicine Wuhan NO.1 Hospital, Hubei Province, Wuhan 430061, China;
4.the First Clinical College, Hubei University of Chinese Medicine, Hubei Province, Wuhan 430065, China |
|
|
Abstract Objective To study the effect of Bushen Huatan Decoction on bone remodeling balance in ovariectomized osteoporosis rats. Methods Thirty-six month old female SD rats were divided into three groups: sham operation group, model group and traditional Chinese medicine group according to the random number table method, with 10 rats in each group. In sham operation group and traditional Chinese medicine group, the model was made by ovariectomy. In sham operation group, only the same amount of fat was removed. 5 weeks after operation, rats in traditional Chinese medicine group were given Bushen Huatan Decoction, and rats in sham operation group and model group were given the same amount of normal saline. 12 weeks after rats were killed, the content and localization of bone morphogenetic protein 2 (BMP2), runt related transcription factor 2 (RUNX2), osteoprotegerin (OPG), nuclear factor kappa B receptor activating factor ligand (RANKL) in serum and bone tissue were detected by enzyme-linked immunosorbent assay, Western blot and immunohistochemistry respectively. Bone mineral density of rats was measured by micro CT, and the differences of each index between each group were analyzed. Results Bone mineral density and serum BMP2, RUNX2, OPG and OPG/RANKL contents of model group and traditional Chinese medicine group were lower than those of sham operation group, and RANKL content was higher than that of sham operation group, with statistically significant differences (P < 0.05). Bone mineral density and serum BMP2, RUNX2, OPG, OPG/RANKL content of the rats in traditional Chinese medicine group were higher than those in model group, and RANKL content was lower than that in model group, with statistically significant difference (P < 0.05). BMP2, RUNX2, OPG and OPG/RANKL gray values of bone tissue in model group and traditional Chinese medicine group were lower than those in sham operation group, and the RANKL gray values were higher than those in sham operation group (P < 0.05). BMP2, RUNX2, OPG and OPG/RANKL gray values of bone tissue in traditional Chinese medicine group were higher than those in model group, and RANKL gray values were lower than those in model group, the differences were statistically significant (P < 0.05). The results of immunohistochemistry showed that the positive expression of BMP2, RUNX2 and OPG was mainly located in the cytoplasm of bone marrow stromal cells and osteoblasts around the trabecula; the positive expression of RANKL was located in osteoclasts at the border of bone, which were brownish yellow granules. Conclusion Bushen Huatan Decoction can regulate bone remodeling balance through BMP2/Smad/RUNX2 signal pathway and OPG/RANKL/RANK signal pathway to treat postmenopausal osteoporosis.
|
|
|
|
|
[1] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-444.
[2] 於绍龙,刘丹平.成骨因子BMP-2/Smads/Runx2信号转导通路[J].辽宁医学院学报,2014,35(5):94-96.
[3] 李盛村,鲍捷,王静,等.骨保护素/核因子-κB受体活化因子配体/核因子-κB受体活化因子信号通路与骨质疏松的研究进展[J].中国康复理论与实践,2014,20(3):250-252.
[4] 谢平金,柴生颋.中医药治疗绝经后骨质疏松症研究进展[J].辽宁中医药大学学报,2018,20(3):144-148.
[5] 明·李时珍.增补本草纲目[M].北京:中国医药科技出版社,2016:385,507.
[6] 元·朱丹溪.丹溪心法[M].北京:中国医药科技出版社,2018:63.
[7] 周亚娜,向楠,陈辉.补肾化痰法影响骨髓间充质干细胞成骨分化的实验研究[J].中国中医基础医学杂志,2015, 21(3):275-277.
[8] 周广文,向楠,周亚娜,等.补肾化痰方对去势骨质疏松大鼠钙沉积的影响[J].中国骨质疏松杂志,2018,24(3):366-370.
[9] 周广文,向楠,张妍,等.高通量测序研究补肾化痰方对去势骨质疏松大鼠肠道菌群结构与多样性的影响[J].中华中医药杂志,2019,34(7):3305-3310.
[10] 李建国,谢兴文,李宁,等.绝经后骨质疏松症的中医脏腑认识及治疗现状[J].中国中医基础医学杂志,2019, 25(3):410-412,420.
[11] 邓昶,周明旺,付志斌.骨质疏松症的中医病因病机及其治疗进展[J].中国骨质疏松杂志,2017,23(8):1105-1111.
[12] 张冰雨,曾瑞翔,雷涛.脂代谢与骨代谢相关机制的研究进展[J].中国骨质疏松杂志,2015,21(10):1263-1266.
[13] 李维娜,冯玲,隋歌川.从痰浊论治高脂血症研究进展[J].山东中医杂志,2017,36(5):430-433.
[14] 周亚娜,向楠.从“痰”论治骨质疏松症[J].湖北中医杂志,2013,35(12):36-38.
[15] 闫慧明,郭静,安燕,等.分子信号通路在骨质疏松症发生机制中的研究进展[J].中国骨质疏松杂志,2016,22(10):1336-1340.
[16] 高璐,郑洪新,陈谊敬,等.淫羊藿苷、补骨脂素、齐墩果酸、二苯乙烯苷正交配伍调控Bmp2、Smad1、4诱导BMSCs成骨分化的影响[J].世界科学技术-中医药现代化,2014,16(5):1094-1102.
[17] 李雪,周延民,马珊珊,等.RANK-RANKL-OPG 信号通路在骨重建中的分子作用机制[J].口腔医学研究,2016, 32(6):659-662.
[18] 宋敏,罗晓,李宁,等.淫羊藿总黄酮含药血清对成骨细胞OPG/OPGL基因表达的影响[J].时珍国医国药,2012, 23(4):883-886.
[19] 周倚墨,张建宁,单中书.补骨脂提取物干预骨质疏松模型大鼠骨密度及骨生物力学的变化[J].中国组织工程研究,2020,24(2):165-170.
[20] 赵素霞,刘会丽,江红.菟丝子黄酮通过调节Wnt/β-catenin信号通路干预去卵巢大鼠骨代谢的机制研究[J].临床和实验医学杂志,2018,17(1):25-28.
[21] 沈家峰,卢建华,徐孝平,等.红曲对去卵巢大鼠骨组织RANKL、OPG蛋白和mRNA表达的影响[J].中华中医药杂志,2018,33(4):1370-1372.
[22] 卢建华,卢烨超,金红婷,等.红曲对去卵巢大鼠骨质疏松模型血清ALP,TRAP及骨组织TNF-α,RANK表达的影响[J].中国中医骨伤科杂志,2017,25(9):5-8. |
|
|
|